Mentor Research Interests
- Ronald L. Ariagno, M.D.
Department of Pediatrics
Division of Neonatal and Developmental Medicine
Research: Infant brain development, injury, and prediction of neurodevelopmental outcome; Sleep, arousal and circadian development; Brain homeostasis mechanisms and sudden infant death syndrome (SIDS) - Ann M. Arvin, M.D.
Department of Pediatrics
Division of Infectious Diseases
Research: Host-virus interactions of herpes viruses in the fetus and newborn. - Ben A. Barres, M.D., Ph.D.
Department of Neurobiology
Research: Development and function of glia. - Richard D. Bland, M.D.
Department of Pediatrics
Division of Neonatal and Developmental Medicine
Research: Dr Bland's research program (sponsored by 2 NIH grants) focuses on the pathogenesis and prevention of neonatal chronic lung disease (bronchopulmonary dysplasia, BPD), with particular emphasis on understanding mechanisms that contribute to disordered elastin deposition and associated impairment of alveolar and pulmonary vascular development that occur in BPD. The research includes studies of various genes that are thought to regulate the synthesis, assembly and degradation of elastin in lung tissue obtained from lambs with chronic lung injury produced by 3-4 weeks of mechanical ventilation after premature birth. Studies have been done to investigate the impact of specific therapeutic interventions, including high-frequency mechanical ventilation, inhaled nitric oxide, retinol, and l-arginine, on the pathophysiology and histopathology of neonatal chronic lung disease in preterm lambs. A new element of this project examines the effects of prolonged, repetitive stretch and associated inflammation on extracellular matrix proteins, alveolar, and vascular development in lungs of newborn mice. - Helen M. Blau, Ph.D.
Department of Genetic Pharmacology Program in Gene Therapy
Research: Molecular basis for the genetic regulation of cell differentiation during development and disease; using muscle as a model system; gene therapy. - Chang-Zheng Chen, Ph.D.
Department of Microbiology and Immunology
Research: MicroRNAs in lymphoid development and cancer. - Christopher H. Contag, Ph.D.
Department of Pediatrics
Division of Neonatal and Developmental Medicine
Research: Our laboratory is interested in studying a variety of biological processes using a non-invasive approach for monitoring functional changes in living animal models of human development and disease. These biological processes include infection and treament, tumor progression and therapy, and normal and pathologic gene expression. - Gerald Crabtree, M.D.
Department of Developmental Biology
Department of Pathology
Research: Regulation in cell proliferation and differentiation, genetic regulatory mechanisms in T-lymphocyte activation; lymphoid development. - David Epel, Ph.D.
Department of Biological Sciences
Department of Marine Biology
Research: Our studies of fertilization have contributed to understanding how developmental programs in eggs are initiated. Recently we have turned our attention to how development takes place in the marine environment, especially how embryos resist the effects of such environmental stresses as ultraviolet radiation, pathogens, and as well as natural man-made toxins. - Heidi M. Feldman, M.D., Ph.D
Department of Pediatrics
Development and Behavioral Pediatrics
Research: Long-standing research interests in child language. The study of typical development and variety of clinical conditions that put language learning at risk, either because the condition alters access to environmental input or to the neural substrates that usually process language. - Dean Felsher, M.D., Ph.D.
Department of Medcine
Division of Oncology and Pathology
Research: Dr. Dean Felsher's expertise brings a new field of research for our program in the area of how oncogenes initiate and sustain tumorigenesis. He has developed model systems whereby he can conditionally activate oncogenes in normal human and mouse cells in tissue culture or in specific tissues of transgenic mice. - Andrew Fire
Research: Our lab studies the mechanisms by which cells and organisms respond to genetic change. At the root of these studies are questions of how a cell can distinguish "self" versus "nonself" and "wanted" versus "unwanted" gene expression. Much of the current effort in the lab is directed toward a molecular understanding of the RNAi machinery and its roles in the cell. RNAi is not the only cellular defense against unwanted nucleic acid, and substantial current effort in the lab is also directed at identification of other triggers and mechanisms used in recognition and response to foreign information. - Margaret T. Fuller, Ph.D.
Department of Developmental Biology
Department of Genetics
Research: Regulation of Stem Cell Behavior, cell type specific transcription machinery and tissue specific gene expression; regulation of the meiotic cell cycle; cell morphogenesis. mechanism of cytokinesis. - Rona G. Giffard, M.D.
Department of Anesthesia
Research: Anesthetics and ischemic neuronal injury and astrocyte injury in vitro; primary cell culture; gene expression and protection from ischemic injury, stress proteins, Hsp-70, Bcl-2, role of astrocytes in brain injury and protection; neuronal astrocyte interactions. - Jeffrey B. Gould, M.D., Ph.D.
Department of Pediatrics
Division of Neonatal and Developmental Medicine
Research: Looking at the impact of low cesarean section rates on morbidity and trying to develop a morbidity index that could be used to assess the quality of perinatal care. - Louis P. Halamek, M.D.
Department of Pediatrics
Division of Neonatal and Developmental Medicine
Research: The use of simulation-based and virtual reality-based technologies in medical education, human performance, and patient safety. - Dale A. Kaiser, Ph.D.
Department of Biochemistry
Department of Developmental Biology
Research: How are genes regulated to construct a developmental program? How do signals received from other cells change the program and coordinate it for multicellular development? The approach taken by our laboratory group to answer these questions utilizes biochemistry and genetics; genetics to isolate mutants that have particular defects in development and biochemistry to determine the molecular basis of the defects. We study fruiting body development in Myxococcus xanthus, a social bacterium. - Mark A. Kay, M.D., Ph.D.
Department of Pediatrics
Division of Genetics
Research: The focus is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired diseases. The general approach is to develop new vector systems and delivery methods, test them in the appropriate animal models, and use the most promising approaches in clinical trials. Specifically, we work on a variety of viral and non-viral vector systems. Our two major disease models are hemophilia and hepatitis C virus infection. - Seung K. Kim, M.D., Ph.D.
Department of Developmental Biology
Department of Medicine
Research: We study the genetics of pancreatic islet cell differentiation using molecular, embryologic and genetic methods in several model systems, including mice, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. Our knowledge of genetic and cellular pathways governing islet formation has allowed us to use stem cell lines to produce functional islets in vitro. - David M. Kingsley, Ph.D.
Department of Developmental Biology
Research: My laboratory uses a variety of genetic, cellular, and molecular approaches to study skeletal development in humans, mice, and stickleback fish. Many of our studies begin with naturally occuring genetic traits that alter normal skeletal development. By isolating the genes responsible for these traits, it has been possible to identify key genetic pathways that control skeletal patterning and skeletal disease in mice and humans. Similar genetic studies in sticklebacks are making it possible to determine how new morphological and physiological traits arise during vertebrate evolution. - Mark A. Krasnow, M.D., Ph.D.
Department of Biochemistry
Research: Genetic, genomic, and cellular analysis of epithelial morphogenesis in Drosophila and mouse. - David B. Lewis, M.D.
Department of Pediatrics
Division of Immunology and Transplantation Biology
Research: My laboratory has three major research interests. First, to define cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. Second, to determine how exposure to respiratory viral infections, alters the development of allergen-induced asthma. Third, to determine how immune responses to cytomegalovirus may influence allograft rejection. - Liqun Luo, Ph.D.
Department of Biological Sciences
Research: Molecular genetics in the fruit fly Drosophila melanogaster and rodents to study how neurons elaborate their dendrites and guide their axons, and how neural circuits are formed during development. - Susan McConnell, Ph.D.
Department of Biological Sciences
Research: Exploring the mechanisms by which neurons in the mammalian
central nervous system achieve their normal fates during development. - Fernando Mendoza, M.D., M.P.H.
Department of Pediatrics
Division of General Pediatrics
Research: Major research interest have been in the area of minority health care research principally focused on child health. Prior research has examined the health care status of Latino children and adolescents in the United States. This program has examined growth patterns of children, chronic illness, health perceptions, and health care utilization. This has provided the basis to begin to develop health policy recommendations for Latino children and adolescents. Ongoing research continues to examine various health parameters for Latino children and trying to identify risk factors for poor heatlh outcomes among these children. - Elizabeth D. Mellins, M.D.
Department of Pediartrics
Division of Immunology and Transplantation Biology
Research: Molecular mechanisms and intracellular pathways of antigen processing and presentation; structure/function of HLA-DR, -DM, -DO; pathogen evasion of the class II pathway. - Daria Mochly-Rosen, Ph.D.
Department of Molecular Pharmacology
Research: We are studying the mechanism of protein kinase C-mediated signal transduction in several disease models. Based on our recent data, we proposed a working hypothesis that activated PKC isozymes bind to intracellular receptor proteins located at different subcellular sites, and that these receptors differentially bind specific PKC isozymes. - Nihar Nayak, DVM, Ph.D.
Department of Obstetrics and Gynecology
Division of Maternal Fetal Medicine
Research: Molecular basis of endometrial angiogenesis and vascular
remodeling during the menstrual cycle and pregnancy, particularly vascular
abnormalities in implantation that may lead to various complications of
pregnancy, including preeclampsia. - Garry P. Nolan, Ph.D.
Department of Molecular Pharmacology
Research: Biochemistry of NF-kB/IkB factors, nuclear oncoproteins p50 and Bc1-3; Rel/ankyrin proteins, and HIV regulations. - Roeland Nusse, Ph.D.
Department of Developmental Biology
Research: The elucidation of the mechanism of action of oncogenes in embryogenesis and to extrapolate these findings to cancerous growth. - Charles G. Prober, M.D.
Department of Pediatrics
Division of Infectious Diseases
Research: The epidemiology and management of perinatal viral infections. - Marlene Rabinovitch, M.D.
Department of Pediatrics
Division of Cardiology
Research: We investigate mechanisms regulating vascular cell development to discover novel ways to reverse cardiovascular and pulmonary disease. Our approaches include targeted gene therapy, transgenic mouse models, and gene arrays. Our focus is on novel vascular elastase and chymase gene, regulation of their transcription factors which include AML1; expression of a calcium binding protein, Mts1; and on a microtubule-associated protein regulating mRNA translation. - Renee A. Reijo Pera, Ph.D.
Department of Obstetrics and Gynecology
Research: The Reijo Pera Laboratory is focused on understanding key cell fates in the embryo, including the generation of pluripotent stem cells, somatic and germ cell lineages. - Matthew P. Scott, Ph.D.
Department of Developmental Biology
Department of Genetics
Research: Genetic regulation of animal development and human disease. We study homeobox genes, hedgehog/patched signaling and its links to skin and brain cancer, development of the neural tube and cerebellum, Wnt signaling, and heart development. - Eric Sibley, M.D.
Department of Pediatrics
Division of Gastroenterology
Research: Transcriptional Regulation of Lactase During Intestinal Development. The mammalian gastrointestinal tract matures from a primitive tube into morphologically and functionally distinct regions during development. The mature small intestine functions in the digestion and absorption of ingested nutrients. - David K. Stevenson, M.D.
Department of Pediatrics
Division of Neonatal and Developmental Medicine
Research: Heme and bilirubin metabolism in the neonate utilizing non-invasive technologies combined with developmental biochemistry approaches. - William S. Talbot, Ph.D.
Department of Developmental Biology
Research: We use genetic and genomic approaches to investigate the molecular basis of cell fate specification and morphogenesis in the zebrafish embryo. Other projects include the genetic dissection of myelination and functional genomics in zebrafish. - Irving L. Weissman, M.D.
Department of Developmental Biology
Research: Developmental biology and function of lymphocytes using multiple disciplines to study these cells, ranging from molecular biology to the whole animal.
Application Instructions
Stanford University Medical Center (Stanford Health Services) believes that a residency and fellowship program that is composed of individuals who are both highly qualified and diverse in terms of culture, gender, race, ethnicity, background, work and life experiences, skill, and interests is essential to the postgraduate education of physicians. Because of its strong belief in the value of diversity, SUMC (The Training Program) especially encourages applications from African-Americans, Hispanics, Native Americans, Alaskan Natives and Pacific Islanders, as well as from others who have disabilities or come from a disadvantaged background, whose backgrounds and experience provide additional dimensions that will enhance the Developmental and Neonatal Biology Training Program.
Requirements
To be appointed to a research training grant, an individual must be a citizen, a non-citizen national of the United States or must have been lawfully admitted for permanent residence (i.e., in possession of a current, valid Alien Registration Receipt Card I-551, or must be in possession of other legal verification of such status). Individuals on temporary or student visas are not eligible.
Predoctoral Trainees
Predoctoral trainees must have received a baccalaureate degree by the beginning date of their NRSA appointment and must be training at the post-baccalaureate level in a program leading to the Ph.D. in science or in an equivalent research doctoral degree program. Health-professional students who wish to interrupt their studies for a year or more to engage in full-time research training before completing their professional degrees are also eligible.
Postdoctoral Trainees
Postdoctoral trainees must have received, as of the beginning date of the NRSA appointment, a Ph.D., M.D. or comparable doctoral degree from an accredited domestic or foreign institution. Written certification by an authorized official of the degree-granting institution that all degree requirements have been met, prior to the date training is to begin, is acceptable.
Please download the application paperwork:
- Brochure 48k Word doc | 107k PDF
- Checklist 20k Word doc | 38k PDF
- PRE-DOCTORAL Application 8k Word doc | 471k PDF
- POST DOCTORAL Application 45k Word doc | 76k PDF
You may also request an application:
Stanford University, School of Medicine
Department of Pediatrics
Division of Neonatal and Developmental Medicine
750 Welch Rd., Suite 315
Palo Alto, CA 94304
(650) 723-5711
(650) 725-8351 (FAX)
Post-Residency Fellowship Program in Neonatal-Perinatal Medicine
The Post-Residency fellowship progam in neonatal-perinatal medicine, based in the Division of Neonatal & Developmental Medicine in the Department of Pediatrics, is three years in length and designed for those who desire a career in academic medicine. Fellows devote approximately two-thirds of their time to research endeavors and the remainder to clinical care.Application Process - Post-Residency Fellowship
Application season for 2010 neonatal-perinatal medicine fellowships has closed. For fellowships beginning July 1, 2011, our program will use the Association of American Medical Colleges' Electronic Residency Application Service (ERAS) and participate in the National Resident Matching Program (NRMP). All positions will be filled through the NRMP system. Post-residency applications must be submitted through ERAS. Paper applications will no longer be accepted.
To register with ERAS and review information regarding application procedures, requirements, and deadlines, please visit http://www.aamc.org/students/erasfellow/start.htm
Please visit the NRMP’s website at http://www.nrmp.org/fellow/match_name/neonatal-perinatal/about.html for details regarding the match process and registration information.
The application, interview, and acceptance process for 2011 fellowships follows the outline below. Applicants are encouraged to contact the Division office to monitor the progress of their applications and ensure all required documentation is received.
| Time of Year | Step in Application Process |
July 1, 2009 |
• MyERAS Web site opens to applicants. |
| August - November 2009 | Programs update their web sites to provide information to applicants about what to submit via ERAS, deadlines, etc. |
November 15, 2009 |
Fellowship applicants may begin selecting and applying to December application cycle fellowship programs. |
December 1, 2009 |
December application cycle fellowship programs may begin contacting the ERAS PostOffice to download and review application files. |
May 31, 2010 |
ERAS Post Office closes to prepare for the 2011 season. Application Submission Deadline for 2011 fellowships. |
March - June 2010 |
Fellowship Interviews conducted. |
July 1, 2011 |
Training begins for fellows. |
Required Documentation to be Submitted via ERAS:
- Complete ERAS Application
- Medical School Transcript (certified English translation if from foreign institution)
- Three letters of recommendation (more than three is optional)
- Personal Statement
- Current CV
- USMLE transcript with scores to date
- MSPE/Dean's Letter (Required for U.S. medical schools; provide if available for foreign medical schools)
- Photograph for ERAS system (optional)
Out-of-State and Out-of-Country Scholars
The Division of Neonatal and Developmental Medicine welcomes out-of-state and out-of-country scholars; however, we do not provide advice or support for becoming legally able to practice medicine in the state of California. All post-residency clinical trainees must have a California Medical License prior to beginning their fellowship. Applicants with J1 Visas are eligible to apply. The Post-residency fellowship program cannot sponsor H1B Visas. Please visit the following web sites for information:
- California Medical License:
www.medbd.ca.gov - USMLE III:
www.usmle.org - ECFMG (Educational Commission on Foreign Medical Graduates):
www.ecfmg.org
